Cytosorbents Corp expected to post a loss of 90 cents a share - Earnings Preview
Cytosorbents Corp expected to post a loss of 90 cents a share - Earnings Preview
Cytosorbents Corp CTSO.OQ CTSO.O is expected to show a rise in quarterly revenue when it reports results on November 12 for the period ending September 30 2026
The Princeton New Jersey-based company is expected to report a 4.5% increase in revenue to $9.915 million from $9.49 million a year ago, according to the mean estimate from 2 analysts, based on LSEG data.
LSEG's mean analyst estimate for Cytosorbents Corp is for a loss of 90 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Cytosorbents Corp is $15.00, about 240.9% above its last closing price of $4.40
This summary was machine generated October 30 at 11:19 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)